32 related articles for article (PubMed ID: 6262466)
1. Extra-cardiac uptake on technetium-99m pyrophosphate (Tc-99m PYP) scan: not just a matter of the heart.
Khor YM; Dorbala S
J Nucl Cardiol; 2023 Dec; 30(6):2540-2543. PubMed ID: 37468745
[No Abstract] [Full Text] [Related]
2. Effect of vitamin D3, other drugs altering serum calcium or phosphorus concentrations, and desoxycorticosterone on the distribution of Tc-99m pyrophosphate between target and nontarget tissues.
Carr EA; Carroll M; Montes M
J Nucl Med; 1981 Jun; 22(6):526-34. PubMed ID: 6262465
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
5. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
Armas R; Neumann R; Goldsmith SJ
J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
[No Abstract] [Full Text] [Related]
7. Drug-induced modulation of Tc-99m pyrophosphate tissue distribution: what is involved?
Wahner HW; Dewanjee MK
J Nucl Med; 1981 Jun; 22(6):555-9. PubMed ID: 6262466
[No Abstract] [Full Text] [Related]
8. [Value of myocardial scintigraphy with 99m Tc-pyrophosphate in the diagnosis of ischemic heart disease].
Botnar' VI; Dvoskina IS
Med Radiol (Mosk); 1983 Oct; 28(10):53-8. PubMed ID: 6314083
[No Abstract] [Full Text] [Related]
9. [Cardiac amyloidosis].
Jantunen E; Collan Y; Halinen MO; Kosma VM
Duodecim; 1987; 103(4):192-8. PubMed ID: 3038501
[No Abstract] [Full Text] [Related]
10. [Radionuclide study of reparative osteogenesis].
Sveshnikov AA; Smotrova LA; Mingazova NB
Med Radiol (Mosk); 1985 Jun; 30(6):61-6. PubMed ID: 2991697
[No Abstract] [Full Text] [Related]
11. Infarct avid (hot spot) myocardial scintigraphy.
Holman BL; Wynne J
Radiol Clin North Am; 1980 Dec; 18(3):487-99. PubMed ID: 6256808
[TBL] [Abstract][Full Text] [Related]
12. Effects of renal failure and metabolic diseases upon bone scanning in children.
Schümichen C
Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
